Electrical impedance myography (EIM) is highly reliable in children even when measurements are made days apart and by different evaluators. EIM reliability is high whether evaluating single muscles or multiple muscles in combination. The reliability of EIM in healthy children and those with Duchenne muscular dystrophy is similar.
h i g h l i g h t s
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a b s t r a c t
Objective: High reliability is a prerequisite for any test to be useful as a biomarker in a clinical trial. Here we assessed the reproducibility of electrical impedance myography (EIM) in children by comparing data obtained by different evaluators on separate days. Methods: Healthy boys and boys with Duchenne muscular dystrophy (DMD) aged 2-14 years underwent EIM of multiple muscles performed by two evaluators on two visits separated by 3-7 days. Single and multifrequency data were analyzed. Reliability was assessed via calculation of the percent relative standard deviation (% RSD), Bland-Altman analysis, and the intraclass correlation coefficient (ICC). Results: For both individual muscle data and data averaged across muscles, intra-evaluator measurements showed high repeatability for both 50 kHz phase and 50/200 kHz phase ratio values, with ICCs generally above 0.90 and % RSD below 10%. Inter-evaluator results showed very similar ICC and % RSD values as those obtained by the same evaluator. Conclusions: Both the 50 kHz phase and 50/200 kHz phase ratio are reliable measures both across time and evaluators and in both health and disease. Significance: These results support the concept that EIM can serve as a reliable measure in clinical therapeutic trials in a pediatric population. Ó 2014 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.
Introduction
Better measures that can serve as reliable biomarkers of disease severity and drug effect in neuromuscular disease clinical trials are needed. For example, recent and ongoing clinical therapeutic trials in Duchenne muscular dystrophy (DMD) have relied on the 6-min walk test or muscle biopsy as the major outcome measures of drug efficacy (Finkel et al., 2013; McDonald et al., 2013) . However, such measures are limited for many reasons. The 6 min walk test can be utilized in only a subset of boys -namely those who are ambulatory above the age of 5 years, requires considerable training for investigators to perform well, and has sufficient variability to have negatively impacted the results of at least two recent clinical trials (Hoffman and Connor, 2013) . Although muscle biopsy for dystrophin staining has also been used especially in early-stage trials, it is impractical in larger trials and its relationship to functional improvement remains uncertain.
Electrical impedance myography (EIM) is a measure that is showing promise for the quantification of neuromuscular disease severity (Rutkove, 2009) . In EIM, a weak, electrical current at multiple high frequencies (generally over 10 kHz) is applied to a localized area of tissue and the consequent surface voltages are measured. From these voltages, the complex impedance can be calculated, which includes the reactance (X), the resistance (R) from 
